A carregar...

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Statin therapy in patients with cardiovascular disease is associated with reduced incidence of stroke. The Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) trial showed daily treatment with 80 mg of atorvastatin in patients with a recent stroke or transient ischemic attack (T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huisa, Branko N, Stemer, Andrew B, Zivin, Justin A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856578/
https://ncbi.nlm.nih.gov/pubmed/20407630
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!